Interpace Diagnostics Receives Regional Award as 2018 Top Life Sciences Company
March 04, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, March 04, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or “the Company”) announced today that the Pittsburgh Business Times has designated Interpace...
Interpace Diagnostics Announces Preliminary 2018 Revenues
February 28, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Interpace to Host Fourth Quarter and Full Year 2018 Results Conference Call/Webcast PARSIPPANY, NJ, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGEN®
February 19, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that BMJ Open Gastroenterology, an on-line, peer-reviewed, open access...
Interpace Diagnostics to Attend BIO CEO & Investor Conference in New York City
February 04, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced the Company will attend the 21st BIO CEO & Investor Conference being held in New...
Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock
January 29, 2019 16:20 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the closing of its previously announced...
Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock
January 25, 2019 06:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the pricing of an underwritten public offering of...
Interpace Diagnostics Announces Proposed Public Offering of Common Stock
January 24, 2019 16:35 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) announced today that it intends to offer and sell shares of its...
Interpace Diagnostics to Present at the Fifteenth Annual NobleCon
January 24, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced that Jack Stover, Chief Executive Officer, will present at NobleConXV - Noble Capital...
Interpace Diagnostics Announces Further Expansion of Thyroid Business
January 22, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Interpace Only Provider Validated to Offer MDx Tests on Three Distinct Platforms PARSIPPANY, NJ, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) announced today that it...
Interpace Diagnostics Enters into Agreement with University of Maryland Medical System
January 14, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Agreement Provides Access to Company’s Available Molecular Diagnostic Tests PARSIPPANY, NJ, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) has entered in to an...